A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy

References

• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr;61(2):69–90. PubMed PMID: 21296855.
   PubMed Web of Science ®Google Scholar
• Tseng LM, Liu CY, Chang KC, et al. CIP2A is a target of bortezomib in human triple negative breast cancer cells. Breast Cancer Res. 2012 Apr 26;14(2):R68. PubMed PMID: 22537901; PubMed Central PMCID: PMCPMC3446403.
   PubMed Web of Science ®Google Scholar
• Pal SK, Childs BH, Pegram M. Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat. 2011 Feb;125(3):627–636.. PubMed PMID: 21161370; PubMed Central PMCID: PMCPMC3244802.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005 Sep;5(9):726–734. PubMed PMID: 16148885.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Pietrocola F, Bravo-San Pedro JM, et al. Autophagy in malignant transformation and cancer progression. Embo J. 2015 Apr 1;34(7):856–880. PubMed PMID: 25712477; PubMed Central PMCID: PMCPMC4388596.
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, et al. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol. 2011 May 17;8(9):528–539. PubMed PMID: 21587219.
   PubMed Web of Science ®Google Scholar
• Buchser WJ, Laskow TC, Pavlik PJ, et al. Cell-mediated autophagy promotes cancer cell survival. Cancer Res. 2012 Jun 15;72(12):2970–2979. PubMed PMID: 22505650; PubMed Central PMCID: PMCPMC3505669.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ. 2005 Nov;12(Suppl 2):1528–1534. PubMed PMID: 16247500.
   PubMed Web of Science ®Google Scholar
• Lee KH, Hsu EC, Guh JH, et al. Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator. J Biol Chem. 2011 Nov 11;286(45):39247–39258. PubMed PMID: 21917926; PubMed Central PMCID: PMCPMC3234749.
   PubMed Web of Science ®Google Scholar
• Rao R, Balusu R, Fiskus W, et al. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol Cancer Ther. 2012 Apr;11(4):973–983. PubMed PMID: 22367781.
   PubMed Web of Science ®Google Scholar
• Wang K, Gao W, Dou Q, et al. Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer. Autophagy. 2016 Sep;22(1–2). PubMed PMID: 27657889. DOI:10.1080/15548627.2016.1231494.
   Google Scholar
• Jing Z, Fei W, Zhou J, et al. Salvianolic acid B, a novel autophagy inducer, exerts antitumor activity as a single agent in colorectal cancer cells. Oncotarget. 2016 Sep 20;7(38):61509–61519. PubMed PMID: 27557491; PubMed Central PMCID: PMCPMC5308668.
   PubMedGoogle Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. PubMed PMID: 26799652; PubMed Central PMCID: PMCPMC4835977.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010 Feb 5;140(3):313–326. PubMed PMID: 20144757; PubMed Central PMCID: PMC2852113.
   PubMed Web of Science ®Google Scholar
• Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000 Oct 13;103(2):253–262. PubMed PMID: 11057898.
   PubMed Web of Science ®Google Scholar
• Shi J, Wang H, Guan H, et al. IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways. Cell Death Dis. 2016 Mar;10(7):e2133. PubMed PMID: 26962683; PubMed Central PMCID: PMCPMC4823945.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abeliovich H, Agostinis P, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008 Feb;4(2):151–175. PubMed PMID: 18188003; PubMed Central PMCID: PMCPMC2654259.
   PubMed Web of Science ®Google Scholar
• Bai L, Wang S. Targeting apoptosis pathways for new cancer therapeutics. Annu Rev Med. 2014;65:139–155. PubMed PMID: 24188661.
   PubMed Web of Science ®Google Scholar
• Kumagai T, Wakimoto N, Yin D, et al. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Int J Cancer. 2007 Aug 01;121(3):656–665. PubMed PMID: 17417771.
   PubMed Web of Science ®Google Scholar
• Meric-Bernstam F, Gonzalez-Angulo AM. Targeting the mTOR signaling network for cancer therapy. J Clin Oncol. 2009 May 01;27(13):2278–2287. PubMed PMID: 19332717; PubMed Central PMCID: PMCPMC2738634.
   PubMed Web of Science ®Google Scholar
• Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer. 2004 May;4(5):335–348. PubMed PMID: 15122205.
   PubMed Web of Science ®Google Scholar
• Zou Z, Yuan Z, Zhang Q, et al. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy. 2012 Dec 8;(12):1798–1810. PubMed PMID: 23026799; PubMed Central PMCID: PMCPMC3541289. DOI:10.4161/auto.22110.
   PubMed Web of Science ®Google Scholar
• Yang H, He L, Kruk P, et al. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer. 2006 Nov 15;119(10):2304–2312. PubMed PMID: 16894566.
   PubMed Web of Science ®Google Scholar
• Zhang S, Li J, Zhou G, et al. Aurora-A regulates autophagy through the Akt pathway in human prostate cancer. Cancer Biomark. 2017;19(1):27–34. PubMed PMID: 28269749.
   PubMed Web of Science ®Google Scholar
• Zhou LD, Xiong X, Long XH, et al. RNA interference-mediated knockdown of Aurora-B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3-kinase/Akt signaling pathway. Oncol Lett. 2014 Nov;8(5):2063–2068. PubMed PMID: 25295091; PubMed Central PMCID: PMCPMC4186632.
   PubMed Web of Science ®Google Scholar
• Zhu LB, Jiang J, Zhu XP, et al. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-kappaB signaling pathway. Int J Clin Exp Pathol. 2014;7(7):3984–3991. PubMed PMID: 25120775; PubMed Central PMCID: PMCPMC4129010.
   PubMed Web of Science ®Google Scholar
• Lebovitz CB, DeVorkin L, Bosc D, et al. Precision autophagy: will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines? Autophagy. 2015;11(10):1949–1952. PubMed PMID: 26506897; PubMed Central PMCID: PMCPMC4824567.
   PubMed Web of Science ®Google Scholar
• Kenific CM, Debnath J. Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol. 2015 Jan;25(1):37–45. PubMed PMID: 25278333; PubMed Central PMCID: PMCPMC4275311.
   PubMed Web of Science ®Google Scholar
• Fulda S, Kogel D. Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. Oncogene. 2015 Oct 1;34(40):5105–5113. PubMed PMID: 25619832.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res. 2014 Feb 1;74(3):647–651. PubMed PMID: 24459182.
   PubMed Web of Science ®Google Scholar
• Liu R, Li J, Zhang T, et al. Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy. 2014 Jul;10(7):1241–1255. PubMed PMID: 24905460; PubMed Central PMCID: PMCPMC4203550.
   PubMed Web of Science ®Google Scholar
• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018 Jun;19(6):349–364. PubMed PMID: 29618831.
   PubMed Web of Science ®Google Scholar
• Otto T, Horn S, Brockmann M, et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell. 2009 Jan 6;15(1):67–78. PubMed PMID: 19111882.
   PubMed Web of Science ®Google Scholar
• Zheng F, Yue C, Li G, et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun. 2016 Jan;19(7):10180. PubMed PMID: 26782714; PubMed Central PMCID: PMCPMC4735655.
   PubMed Web of Science ®Google Scholar
• O’Reilly EA, Gubbins L, Sharma S, et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 2015 Jun;3:257–275. PubMed PMID: 26676166; PubMed Central PMCID: PMCPMC4661576.
   PubMed Web of Science ®Google Scholar
• Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist. 2007 Dec;12(12):1395–1403. PubMed PMID: 18165616.
   PubMed Web of Science ®Google Scholar
• Marino G, Niso-Santano M, Baehrecke EH, et al. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014 Feb;15(2):81–94. PubMed PMID: 24401948; PubMed Central PMCID: PMCPMC3970201.
   PubMed Web of Science ®Google Scholar
• Vignot S, Faivre S, Aguirre D, et al. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol. 2005 Apr;16(4):525–537. PubMed PMID: 15728109.
   PubMed Web of Science ®Google Scholar
• Shinojima N, Yokoyama T, Kondo Y, et al. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy. 2007 Nov-Dec;3(6):635–637. PubMed PMID: 17786026.
   PubMed Web of Science ®Google Scholar
• Hashimoto I, Koizumi K, Tatematsu M, et al. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer. 2008 May;44(7):1022–1029. PubMed PMID: 18375114.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005 Feb 18;307(5712):1098–1101. PubMed PMID: 15718470.
   PubMed Web of Science ®Google Scholar
• Pratt J, Annabi B. Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells. Cell Signal. 2014 May;26(5):917–924. PubMed PMID: 24462646.
   PubMed Web of Science ®Google Scholar
• Bogani C, Bartalucci N, Martinelli S, et al. mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms. PLoS One. 2013;8(1):e54826. PubMed PMID: 23382981; PubMed Central PMCID: PMCPMC3561413.
   PubMed Web of Science ®Google Scholar
• Bartalucci N, Tozzi L, Bogani C, et al. Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. J Cell Mol Med. 2013 Nov;17(11):1385–1396. PubMed PMID: 24237791; PubMed Central PMCID: PMCPMC4117551.
   PubMed Web of Science ®Google Scholar
• Britschgi A, Andraos R, Brinkhaus H, et al. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. Cancer Cell. 2012 Dec 11;22(6):796–811. PubMed PMID: 23238015.
   PubMed Web of Science ®Google Scholar
• Li J, Kim SG, Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014 Mar 04;19(3):373–379. PubMed PMID: 24508508; PubMed Central PMCID: PMCPMC3972801.
   PubMed Web of Science ®Google Scholar
• Floto RA, Sarkar S, Perlstein EO, et al. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington’s disease models and enhance killing of mycobacteria by macrophages. Autophagy. 2007 Nov-Dec;3(6):620–622. PubMed PMID: 17786022.
   PubMed Web of Science ®Google Scholar
• Perreira M, Jiang JK, Klutz AM, et al. “Reversine” and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem. 2005 Jul 28;48(15):4910–4918. PubMed PMID: 16033270; PubMed Central PMCID: PMCPMC3474371.
   PubMed Web of Science ®Google Scholar
• Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol. 1961 Feb;9:409–414. PubMed PMID: 13764136; PubMed Central PMCID: PMCPMC2224998.
   PubMedGoogle Scholar
• Da Silva SD, Marchi FA, Xu B, et al. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. Oncotarget. 2015 Sep 8;6(26):21950–21963. PubMed PMID: 26110570; PubMed Central PMCID: PMCPMC4673138.
   PubMedGoogle Scholar